AR071312A1 - Proceso para la preparacion de analogos de prostaglandina y sus intermediarios - Google Patents

Proceso para la preparacion de analogos de prostaglandina y sus intermediarios

Info

Publication number
AR071312A1
AR071312A1 ARP090101272A ARP090101272A AR071312A1 AR 071312 A1 AR071312 A1 AR 071312A1 AR P090101272 A ARP090101272 A AR P090101272A AR P090101272 A ARP090101272 A AR P090101272A AR 071312 A1 AR071312 A1 AR 071312A1
Authority
AR
Argentina
Prior art keywords
formula
compound
converting
alkyl
protecting group
Prior art date
Application number
ARP090101272A
Other languages
English (en)
Inventor
Yung Fa Chen
Dechao Meng
Julian Paul Henschke
Yuanlian Liu
Ting Sun
Original Assignee
Scinopharm Taiwan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Taiwan Ltd filed Critical Scinopharm Taiwan Ltd
Publication of AR071312A1 publication Critical patent/AR071312A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/14Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

Intermediarios para preparar análogos de prostaglandina y procesos para preparar análogos de prostaglandina y sus intermediarios. Un compuesto de formula (1) donde R1 representa H, alquilo C1-5 o bencilo, en particular isopropilo. Reivindicacion 1: Un proceso para preparar un análogo de prostaglandina de formula (2) donde R1 representa H, alquilo C1-5, o bencilo; X representa CH2, O o S; Z representa O o NH; y R' representa alquilo C2-4; fenilo opcionalmente sustituido con halogeno, alquilo C1-5, alcoxi C1-4, CF3, polihaloalquilo C2-4, o acilamino C1-3 alifático; heterociclo de 5 o 6 miembros que contiene uno o más heteroátomos seleccionados entre el grupo que consiste en nitrogeno, oxígeno y azufre; cicloalquilo C3-7; o cicloalquenilo C3-7; el proceso comprende los pasos de: (a) convertir un compuesto de formula (3) a un compuesto de formula (4) donde R2 representa un grupo protector de hidroxi; (b) esterificar y desproteger el compuesto de formula (4) para dar un compuesto de formula (1); (c) convertir el compuesto de formula (1) a un compuesto de formula (5) donde R3 representa un grupo protector de hidroxi; (d) hacer reaccionar el compuesto de formula (5) con un compuesto de formula (6) para dar un compuesto de formula (7) donde y representa un complejo metálico, R'' representa un grupo protector de hidroxi, y (e) convertir el compuesto de formula (7) para dar el compuesto de formula (2). Reivindicacion 7: Un proceso para preparar una ciclopentenona de la formula (5) donde R1 representa H, alquilo C1-5, o bencilo; y R3 representa un grupo protector de hidroxi; el proceso comprende los pasos de: (a) convertir un compuesto de formula (3) a un compuesto de formula (4) donde R2 representa un grupo protector de hidroxi; (b) esterificar y desproteger el compuesto de formula (4) para dar un compuesto de formula (1); (c) convertir el compuesto de formula (1) para obtener el compuesto de formula (5).
ARP090101272A 2008-04-09 2009-04-08 Proceso para la preparacion de analogos de prostaglandina y sus intermediarios AR071312A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12352708P 2008-04-09 2008-04-09

Publications (1)

Publication Number Publication Date
AR071312A1 true AR071312A1 (es) 2010-06-09

Family

ID=41164537

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090101272A AR071312A1 (es) 2008-04-09 2009-04-08 Proceso para la preparacion de analogos de prostaglandina y sus intermediarios

Country Status (11)

Country Link
US (3) US7897795B2 (es)
EP (1) EP2274266B1 (es)
JP (1) JP5485980B2 (es)
KR (1) KR101634818B1 (es)
CN (1) CN102056887B (es)
AR (1) AR071312A1 (es)
AU (1) AU2009250938B2 (es)
CA (1) CA2721102C (es)
ES (1) ES2524884T3 (es)
TW (1) TWI367206B (es)
WO (1) WO2009141718A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR071312A1 (es) * 2008-04-09 2010-06-09 Scinopharm Taiwan Ltd Proceso para la preparacion de analogos de prostaglandina y sus intermediarios
KR101045935B1 (ko) 2009-03-11 2011-07-01 연성정밀화학(주) 프로스타글란딘 유도체의 제조방법
EP2454227B1 (en) 2009-07-13 2020-08-19 Patheon API Services Inc. Synthesis of prostanoids
IN2013MN00733A (es) * 2010-10-15 2015-06-12 Scinopharm Kunshan Biochemical Technology Co Ltd
JP2012111720A (ja) * 2010-11-25 2012-06-14 Fuji Flavor Kk 5−ウンデセン酸の製造方法
CN106349138A (zh) * 2011-06-02 2017-01-25 奇诺因私人有限公司 用于制备前列腺素酰胺的新的方法
US9115109B2 (en) 2013-08-15 2015-08-25 Chirogate International Inc. Processes and intermediates for the preparations of isomer free prostaglandins
CA2925927C (en) 2013-09-30 2022-09-06 George Petros Yiannikouros Novel synthesis routes for prostaglandins and prostaglandin intermediates using metathesis
CN105254657B (zh) * 2014-07-10 2018-06-15 台湾神隆股份有限公司 金属催化不对称1,4-共轭加成反应产生前列腺素和前列腺素类似物
JP2015120693A (ja) * 2014-12-19 2015-07-02 サイノファーム (クンシャン) バイオケミカル テクノロジ カンパニー リミテッド ルビプロストンの調製方法
CN105801533B (zh) * 2014-12-30 2019-01-08 常州博海威医药科技股份有限公司 一种制备利马前列腺素的关键中间体及其应用
CN105801534B (zh) * 2014-12-30 2019-01-08 常州博海威医药科技股份有限公司 一种制备利马前列腺素的关键中间体及其应用
WO2017062770A1 (en) 2015-10-08 2017-04-13 Silverberg Noah Punctal plug and bioadhesives
WO2020255164A1 (en) * 2019-06-21 2020-12-24 Council Of Scientific And Industrial Research A chemo-enzymatic process for the preparation of homopropargylic alcohol
IL295357A (en) 2020-02-06 2022-10-01 Ocular Therapeutix Inc Preparations and methods for the treatment of eye diseases
CN113105329B (zh) * 2021-04-22 2023-10-03 成都道合尔医药技术有限公司 一种(e)-甲酯3-(3,5-二氟-4-甲酰基苯基)丙烯酸的合成方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1000000A (en) * 1910-04-25 1911-08-08 Francis H Holton Vehicle-tire.
GB1384024A (en) 1972-04-14 1974-02-12 Searle & Co Process for the preparation of 3-hydroxy-2-3-hydroxy-1-octenyl- 5-oxocyclopentane-heptanoic acid and derivatives thereof
KR800001263B1 (ko) * 1976-07-28 1980-10-26 퍼시 시드니 죠지플린트 프로스타글란딘류의 제법
JPS5646833A (en) 1979-09-25 1981-04-28 T Hasegawa Co Ltd Preparation of 2-substituted 5-membered cyclic ketone and its intermediate
US4338252A (en) * 1979-09-27 1982-07-06 American Cyanamid Company 1-Descarboxy-1-ketoester (ketoacid)-prostaglandins
US4250321A (en) * 1979-09-27 1981-02-10 American Cyanamid Company 1-Descarboxy-1-ketoester(ketoacid)-protaglandins
US4260805A (en) * 1979-09-27 1981-04-07 American Cyanamid Company 1-Descarboxy-1-ketoester (ketoacid)-prostaglandins
JPH0669984B2 (ja) * 1986-09-19 1994-09-07 住友化学工業株式会社 シクロペンテノン誘導体の製造法
US5106750A (en) * 1988-08-30 1992-04-21 G. D. Searle & Co. Enantio- and regioselective synthesis of organic compounds using enol esters as irreversible transacylation reagents
JP2906062B2 (ja) 1989-08-18 1999-06-14 住友化学工業株式会社 2―フリルカルビノール誘導体の製造法
US5191109A (en) * 1990-02-02 1993-03-02 Sumitomo Chemical Company, Limited Process for preparing optically active cyclopentenones
JP3044898B2 (ja) 1992-02-07 2000-05-22 住友化学工業株式会社 フランカルビノール誘導体の製造方法
WO1995033845A1 (fr) 1994-06-02 1995-12-14 Taisho Pharmaceutical Co., Ltd. Procede de production d'un compose d'alcool propargylique optiquement actif
JP3077878B2 (ja) 1994-08-18 2000-08-21 東光電気株式会社 変成器交換用バイパス開閉器
US5618959A (en) * 1995-03-10 1997-04-08 Vivus Incorporated Process for preparing prostaglandin E1, E2 and analogs thereof using furylcopper reagents
CN1177956A (zh) * 1995-03-10 1998-04-01 维物斯股份有限公司 用呋喃基铜试剂制备前列腺素e1、e2及其类似物的方法
JPH0920788A (ja) * 1995-07-04 1997-01-21 Sumitomo Chem Co Ltd ビニルスズ化合物、その製造方法およびそれを用いるプロスタグランジン類の製造方法
JP4153998B2 (ja) * 1996-11-14 2008-09-24 第一ファインケミカル株式会社 プロスタグランジン類の製造方法
US6214611B1 (en) * 1999-04-12 2001-04-10 Chirotech Technology Limited Process for the preparation of prostaglandin precursors
KR100437873B1 (ko) * 2001-05-08 2004-06-26 연성정밀화학(주) 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
GB0329379D0 (en) * 2003-12-19 2004-01-21 Johnson Matthey Plc Prostaglandin synthesis
US7109371B2 (en) * 2004-01-05 2006-09-19 Johnson Matthey Public Limited Company Prostaglandin synthesis
AR071312A1 (es) * 2008-04-09 2010-06-09 Scinopharm Taiwan Ltd Proceso para la preparacion de analogos de prostaglandina y sus intermediarios

Also Published As

Publication number Publication date
TWI367206B (en) 2012-07-01
EP2274266B1 (en) 2014-10-15
WO2009141718A3 (en) 2010-01-21
US8742143B2 (en) 2014-06-03
CN102056887B (zh) 2014-03-19
US7897795B2 (en) 2011-03-01
JP2011518134A (ja) 2011-06-23
TW201002658A (en) 2010-01-16
WO2009141718A2 (en) 2009-11-26
US20130211128A1 (en) 2013-08-15
EP2274266A4 (en) 2012-10-10
JP5485980B2 (ja) 2014-05-07
AU2009250938B2 (en) 2013-03-07
CA2721102C (en) 2015-12-29
KR20110004432A (ko) 2011-01-13
AU2009250938A1 (en) 2009-11-26
EP2274266A2 (en) 2011-01-19
US8436194B2 (en) 2013-05-07
ES2524884T3 (es) 2014-12-15
KR101634818B1 (ko) 2016-06-29
US20090259058A1 (en) 2009-10-15
US20110130577A1 (en) 2011-06-02
CA2721102A1 (en) 2009-11-26
CN102056887A (zh) 2011-05-11

Similar Documents

Publication Publication Date Title
AR071312A1 (es) Proceso para la preparacion de analogos de prostaglandina y sus intermediarios
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
AR054130A1 (es) Procedimiento para la preparacion de 1-alquil-3-feniluracilos
CO6280485A2 (es) Inhibidores de 11-beta hidroxiesteroide deshidrogenasa tipo i de triazolopiridina
AR074773A1 (es) Piridazinonas sustituidas con fenilo en la posicion 4, su utilizacion como herbicidas e insecticidas en composiciones y metodos que los incluyen e intermediarios para su sintesis.
RS52978B (en) FUSIONED AMINO PIRIDIN AS HSP90 INHIBITORS
PE20070041A1 (es) Amidas de acido pirazolcarboxilico
AR075717A1 (es) Compuestos de 3- aril quinazolin -4- ona para combatir plagas de invertebrados
AR064730A1 (es) Derivados de 2,4-dianilinopirimidinas, su preparacion, composiciones farmaceuticas y usos como inhibidores de ikk
AR100312A1 (es) Compuestos de diaminotriazina
CO6160227A2 (es) Pirazol amidas de acido carboxilico utiles como microbicidas
MX301666B (en) Amide derivatives, process for production of the same, and method for application thereof as insecticide
CO6290658A2 (es) Derivados de azetidina y ciclobutano como inhibidores de jack
AR060489A1 (es) Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol
ECSP088084A (es) Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamidas, su preparación y su aplicación en terapéutica
MA30397B1 (fr) 2-(pyridine-2-yl)-pyrimidines utilisées comme fongicides
AR077363A1 (es) DERIVADOS DE 1,2,3,4- TETRAHIDRO-PIRIMIDO{1,2-A} PIRIMIDIN-6-ONA, SU PREPARACIoN, SU UTILIZACIoN EN QUIMIOTERAPIA Y SUS COMPOSICIONES FARMACEUTICAS.
AR046942A1 (es) Arilpirazoles sustituidos, un procedimiento para su preparacion, composiciones farmaceuticas o veterinarias que los contienen como principio activo y su uso en la fabricacion de un medicamento parasiticida humano o animal.
ES2036852T3 (es) Procedimiento para la obtencion de trifluormetilfenil-azolilmetiloxiranos y su empleo como agentes protectores de las plantas.
AR041861A1 (es) Feniliso (tio) cianatos, procesos e intermediarios para su preparacion.
AR079294A1 (es) Acidos homoglutamico y acidos glutamico marcados con yodo y metodo de preparacion de los mismos
AR051936A1 (es) Proceso para la preparacion de pirazoles
AR054121A1 (es) Compuestos de fenilpiridilpiperazina, procedimiento de preparacion, composiciones farmaceuticas que los contienen, y usos farmacologicos como antagonistas de receptores histaminergicos h3
ECSP045432A (es) Inhibidores de la transcriptasa inversa no nucleosidos
ATE549922T1 (de) Biozidzusammensetzungen enthaltend 2- methylisothiazolin-3-on und ein haloalkylsulfon

Legal Events

Date Code Title Description
FB Suspension of granting procedure